PRESS

Releases

Here are our latest press releases and press articles.

6th February 2020

TargEDys® announces the successful completion of its 3 months, randomized, double blind, placebo-controlled, multicentric clinical study carried out on 229 subjects and evaluating the efficacy of Hafnia alvei HA4597 TM in the weight loss by regulation of the appetite.

Read more

9th October 2019

The French startup TargEDys presents the first natural approach to regulate appetite

Read more

15th July, 2019

TargEDys announces that BIOCODEX has acquired a share of its capital and appoints new board members.

Read more

January 31, 2019

EnteroSatys® is the first probiotic specifically designed to control appetite. It is composed of Hafnia alvei 4597, supplemented with chromium and zinc and is based on patented molecular mimicry technology. A protein produced by H.alvei imitates α-MSH, a hormone that signals satiety.

Read more

15th November 2018

Neovia signs an R&D partnership with TargEDys and continues to innovate on the petcare market

Read more

2nd July, 2018

Philippe Lavielle appointed Chairman of the TargEDys Board of Directors

Read more

04th April 2017

TargEDys extends Series A and appoints new Board Members.

Read more

9th March 2017

Bpifrance soutient TargEDys et lui octroie une aide pour le développement à l’innovation de 1,1 million d’euros.

Read more

18th July 2016

TargEDys, laureate of the International Innovation Contest (CMI)

Read more

27th June 2016

TargEDys and Inserm Transfert on behalf of Rouen Normandy University and Rouen University Hospital (CHU) sign an exclusive international licensing agreement on a patent portfolio in microbiome-based research.

Read more

14th April 2016

TargEDys develops new microbiome -based solutions for appetite regulation and announces a €5.8M international round of financing to demonstrate product clinical efficacy.

Read more